Correlation Between Synlogic and Protara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Synlogic and Protara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Synlogic and Protara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Synlogic and Protara Therapeutics, you can compare the effects of market volatilities on Synlogic and Protara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Synlogic with a short position of Protara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Synlogic and Protara Therapeutics.
Diversification Opportunities for Synlogic and Protara Therapeutics
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Synlogic and Protara is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Synlogic and Protara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protara Therapeutics and Synlogic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Synlogic are associated (or correlated) with Protara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protara Therapeutics has no effect on the direction of Synlogic i.e., Synlogic and Protara Therapeutics go up and down completely randomly.
Pair Corralation between Synlogic and Protara Therapeutics
Given the investment horizon of 90 days Synlogic is expected to under-perform the Protara Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Synlogic is 2.15 times less risky than Protara Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Protara Therapeutics is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest 183.00 in Protara Therapeutics on August 29, 2024 and sell it today you would earn a total of 111.00 from holding Protara Therapeutics or generate 60.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Synlogic vs. Protara Therapeutics
Performance |
| Timeline |
| Synlogic |
| Protara Therapeutics |
Synlogic and Protara Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Synlogic and Protara Therapeutics
The main advantage of trading using opposite Synlogic and Protara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Synlogic position performs unexpectedly, Protara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protara Therapeutics will offset losses from the drop in Protara Therapeutics' long position.The idea behind Synlogic and Protara Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Protara Therapeutics vs. Vaccinex | Protara Therapeutics vs. Monopar Therapeutics | Protara Therapeutics vs. Surrozen | Protara Therapeutics vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |